Pfizer's Viagra revenue worldwide 2003-2019
Pfizer’s worldwide known erectile dysfunction product Viagra generated around 500 million U.S. dollars in revenue in 2019. Sales of this drug have decreased steadily over the past seven years, especially because patent protection expired outside the U.S. in 2012. In the United States, several drug manufacturers are currently allowed to market generic versions of Viagra (sildenafil), even if the patent is set to expire in 2020. This was the reason behind a further significant decline in sales in 2017-2018.
Drug manufacturer Pfizer
Drug manufacturer Pfizer is currently the world’s leading pharmaceutical company based on pure pharmaceutical sales of prescribed and over-the-counter drugs. The company is headquartered in Midtown Manhattan, New York City. Until 2013, the company also had a notable animal health product line. Today, the company is totally focused on human medicine, divided into two major segments - Innovative Health and Essential Health. Pfizer generates nearly half of its revenues inside the United States.
The rise of Viagra
Viagra was developed by scientists that were originally working on a drug for the treatment of hypertension and angina pectoris. During one of the trial phases the ‘adverse effect’ became obvious – while the targeted angina pectoris showed no improvement. Thus, it was approved for the market as an orally administered drug for erectile dysfunction in 1998. Pfizer’s Viagra has surely been one of the best-known and most discussed pharmaceutical products over the last few decades, entering even popular culture and becoming a synonym for potency. The drug, however, is also approved for treating pulmonary arterial hypertension.
Drug manufacturer Pfizer
Drug manufacturer Pfizer is currently the world’s leading pharmaceutical company based on pure pharmaceutical sales of prescribed and over-the-counter drugs. The company is headquartered in Midtown Manhattan, New York City. Until 2013, the company also had a notable animal health product line. Today, the company is totally focused on human medicine, divided into two major segments - Innovative Health and Essential Health. Pfizer generates nearly half of its revenues inside the United States.
The rise of Viagra
Viagra was developed by scientists that were originally working on a drug for the treatment of hypertension and angina pectoris. During one of the trial phases the ‘adverse effect’ became obvious – while the targeted angina pectoris showed no improvement. Thus, it was approved for the market as an orally administered drug for erectile dysfunction in 1998. Pfizer’s Viagra has surely been one of the best-known and most discussed pharmaceutical products over the last few decades, entering even popular culture and becoming a synonym for potency. The drug, however, is also approved for treating pulmonary arterial hypertension.
